71 associate director risk based quality management oncology jobs found

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1-4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards....